OTC Pharmaceuticals Market in Latin America 2014-2018

OTC Pharmaceuticals Market in Latin America 2014-2018

Category : Pharmaceuticals
Published On : January  2014
Pages : 46



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals Market in Latin America has also been witnessing the some key increased outsourcing of drug development activities. However, the stringent regulations are expected to pose a challenge to the growth of this market. 
TechNavio's report, the OTC Pharmaceuticals Market in Latin America Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the OTC Pharmaceuticals Market in Latin America market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG.
Other vendors mentioned in the report are Boehringer Ingelheim GmbH., Genomma Lab Internacional SAB., GlaxoSmithKline plc., Johnson & Johnson, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.
Key questions answered in this report: 
What will the market size be in 2018 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Products

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape


15.1 Competitive Scenario

15.1.1 Key News

15.1.2 Major Vendors

15.2 Other Prominent Vendors

16. Key Vendor Analysis

16.1 Bayer HealthCare AG

16.1.1 Business Overview

16.1.2 Business Segmentation

16.1.3 Key Information

16.1.4 SWOT Analysis

16.2 EMS S.A.

16.2.1 Business Overview

16.2.2 Business Segmentation

16.2.3 Key Information

16.2.4 SWOT Analysis

16.3 Hypermarcas S.A.

16.3.1 Business Overview

16.3.2 Business Segmentation

16.3.3 Key Information

16.3.4 SWOT Analysis

16.4 Novartis AG

16.4.1 Business Overview

16.4.2 Business Segmentation

16.4.3 Key Information

16.4.4 SWOT Analysis

17. Other Reports in this Series



List of Exhibits



Exhibit 1: Market Research Methodology

Exhibit 2: OTC Pharmaceuticals Market in Latin America 2013-2018 (US$ billion)

Exhibit 3: OTC Pharmaceuticals Market in Latin America by Product Segmentation

Exhibit 4: OTC Pharmaceuticals Market in Latin America Segmentation 2013

Exhibit 5: Business Segmentation of Bayer HealthCare AG

Exhibit 6: Business Segmentation of EMS S.A.

Exhibit 7: Business Segmentation of Hypermarcas S.A.

Exhibit 8: Business Segmentation of Novartis AG


Enquiry Before Buy
image
Can´t read the image ? refresh here.